Pharmacokinetics and Pharmacodynamics Practice Questions

Q: Which of the following is a prodrug?

Enalapril. **Explanation:** **Correct Option: A (Enalapril)** A **prodrug** is a pharmacologically inactive compound that must undergo metabolic conversion (usually in the liver) to become an active metabolite [1]. **Enalapril** is an ester prodrug that is hydrolyzed by hepatic esterases into its active form, **Enalaprilat** [2]. Most ACE inhibitors are prodrugs designed to improve oral bioavailability, with two notable exceptions: **Lisinopril and Captopril** (which are active as such) [3]. **Incorrect Options:** * **B. Clonidine:** An alpha-2 adrenergic agonist used in hypertension. It is an active drug and does not require metabolic activation. * **C. Salmeterol:** A long-acting beta-2 agonist (LABA) used in asthma. It is active upon administration to the respiratory tract. * **D. Acetazolamide:** A carbonic anhydrase inhibitor used in glaucoma and mountain sickness. It is an active drug excreted largely unchanged by the kidneys. **High-Yield Clinical Pearls for NEET-PG:** * **ACE Inhibitor Exceptions:** Remember the mnemonic **"L-C"** (Lisinopril and Captopril) are NOT prodrugs. All other ACE inhibitors (Ramipril, Perindopril, etc.) are prodrugs. * **Active Metabolites:** Enalaprilat (the active form of Enalapril) is available only as an intravenous formulation for hypertensive emergencies because it has poor oral absorption. * **Common Prodrugs to Remember:** Levodopa (to Dopamine), Clopidogrel, Prednisone (to Prednisolone), Cyclophosphamide, and Valacyclovir. * **Advantage of Prodrugs:** They are often designed to increase absorption, decrease gastrointestinal toxicity, or prolong the duration of action.

Q: Autoinduction of biotransformation and action as a hormone is seen in:

Thyroxine. **Explanation:** The correct answer is **Thyroxine (D)**. This question tests the dual understanding of metabolic pathways and endocrine physiology. **Why Thyroxine is correct:** 1. **Autoinduction:** Thyroxine ($T_4$) is a unique example of a substance that induces its own metabolism. It stimulates the expression of enzymes responsible for its deiodination and glucuronidation, leading to a self-regulated metabolic rate. 2. **Hormonal Action:** Thyroxine is an endogenous hormone produced by the thyroid gland. It acts on nuclear receptors (TR-$\alpha$ and TR-$\beta$) to regulate gene transcription, affecting basal metabolic rate, growth, and development. **Analysis of Incorrect Options:** * **Carbamazepine (A):** While it is a classic and potent **autoinducer** of CYP3A4 enzymes (leading to a decrease in its own half-life over the first few weeks of therapy), it is a synthetic anticonvulsant drug, not a hormone. * **Cimetidine (B):** This is a potent **enzyme inhibitor** (not an inducer). It inhibits various CYP450 isoenzymes, leading to increased levels of drugs like warfarin and theophylline. * **Corticosteroids (C):** These are hormones (e.g., cortisol) and can induce the metabolism of *other* drugs (enzyme induction), but they are not typically characterized by the specific phenomenon of autoinduction in clinical pharmacology. **NEET-PG High-Yield Pearls:** * **Autoinducers to remember:** Carbamazepine, Phenobarbitone, Rifampicin, and Thyroxine. * **Mechanism of Thyroxine:** It is a pro-hormone; the more active form is $T_3$ (Triiodothyronine), converted via 5'-deiodinase. * **Clinical Note:** Due to autoinduction, the dose of Carbamazepine may need adjustment after the first 2–4 weeks of treatment as plasma levels may drop despite constant dosing.

Q: What is the volume of distribution for chloroquine?

Above 1300 L. **Explanation:** The **Volume of Distribution ($V_d$)** is a theoretical volume that relates the amount of drug in the body to its concentration in the plasma. Chloroquine has an exceptionally high $V_d$ (typically cited between **1300 L to 15,000 L**) because it is highly lipid-soluble and undergoes extensive sequestration into tissues, particularly the liver, spleen, kidneys, and melanin-containing tissues like the retina. **Why Option D is correct:** A $V_d$ exceeding total body water (~42 L) indicates that the drug is not confined to the plasma but is distributed deep into peripheral tissues. Chloroquine’s massive $V_d$ (Above 1300 L) reflects its high tissue binding, which also explains its prolonged half-life (1–2 months). **Why other options are incorrect:** * **Options A & B (5–15 L):** These values represent drugs confined primarily to the plasma (e.g., Heparin) or extracellular fluid (e.g., Aminoglycosides). * **Option C (100–650 L):** While this indicates significant tissue distribution (e.g., Digoxin ~500 L), it still underestimates the extreme sequestration characteristic of Chloroquine. **High-Yield Clinical Pearls for NEET-PG:** * **Loading Dose:** Drugs with a high $V_d$ like Chloroquine require a loading dose to achieve therapeutic plasma concentrations quickly. * **Hemodialysis:** Drugs with a high $V_d$ cannot be effectively removed by hemodialysis because very little drug is present in the circulation. * **Toxicity:** Due to its affinity for melanin, long-term Chloroquine use can lead to **"Bull’s eye maculopathy"** (retinal toxicity). * **Other drugs with high $V_d$:** Digoxin, Amiodarone, and Tricyclic Antidepressants (TCAs).

Q: Therapeutic drug monitoring is advised in all drugs except which one of the following?

Metformin. **Explanation:** Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring drug concentrations in the blood to maintain a constant concentration within a specific **narrow therapeutic window**. **Why Metformin is the Correct Answer:** Metformin is a biguanide used for Type 2 Diabetes. TDM is **not** required for Metformin because its clinical effect (blood glucose levels) can be easily and directly measured using a surrogate marker (HbA1c or blood sugar levels). Furthermore, Metformin has a **wide therapeutic index**, meaning the dose required for efficacy is far below the dose that causes toxicity. **Analysis of Incorrect Options:** * **Phenytoin:** This antiepileptic drug follows **zero-order (non-linear) kinetics** at therapeutic doses. Small dose increments can lead to disproportionately large increases in plasma concentration, necessitating TDM to avoid cerebellar toxicity. * **Tacrolimus & Cyclosporine:** These are calcineurin inhibitors (immunosuppressants) with a **narrow therapeutic index**. Sub-therapeutic levels lead to graft rejection, while supra-therapeutic levels cause significant nephrotoxicity and neurotoxicity. TDM is mandatory for these drugs. **High-Yield Clinical Pearls for NEET-PG:** * **Indications for TDM:** Drugs with a narrow therapeutic index, non-linear kinetics, high inter-individual variation, or when toxicity is difficult to distinguish from the disease itself (e.g., Digoxin). * **Drugs requiring TDM (Mnemonic: "The LiP DiT"):** **The**ophylline, **Li**thium, **P**henytoin, **D**igoxin, **I**mmunosuppressants (Tacrolimus/Cyclosporine), **T**ricyclic Antidepressants. * **TDM is NOT needed when:** The drug has a wide therapeutic index or when the pharmacological effect is easily measurable (e.g., BP for antihypertensives, INR for Warfarin, Blood sugar for Metformin).

Q: Phase-2 reactions in drug metabolism are primarily characterized by which of the following processes?

Conjugation. ### Explanation Drug metabolism (biotransformation) typically occurs in two phases to convert lipid-soluble drugs into water-soluble metabolites for excretion. **1. Why Conjugation is Correct:** Phase-2 reactions are **synthetic reactions** where an endogenous hydrophilic group is attached to the drug or its Phase-1 metabolite. This process is known as **Conjugation**. The primary goal is to significantly increase the polarity and water solubility of the compound, facilitating its excretion via urine or bile. Common Phase-2 reactions include Glucuronidation (most common), Acetylation, Methylation, and Sulfation. **2. Why Other Options are Incorrect:** * **Oxidation (A), Hydroxylation (B), and Cyclization (C):** These are all examples of **Phase-1 (Non-synthetic) reactions**. Phase-1 reactions involve the introduction or unmasking of a functional group (like -OH, -NH2, or -SH) through oxidation, reduction, or hydrolysis. These reactions usually utilize the **Cytochrome P450** enzyme system and often result in metabolites that are still chemically active. **3. High-Yield Clinical Pearls for NEET-PG:** * **Glucuronidation:** The most common Phase-2 reaction; it is the only one that occurs in the microsomal fraction (Smooth Endoplasmic Reticulum). All other Phase-2 reactions are non-microsomal (cytosolic). * **Acetylation:** Shows genetic polymorphism (Fast vs. Slow acetylators). Drugs like **Isoniazid, Hydralazine, and Procainamide** (Mnemonic: **SHIP**) undergo acetylation. * **Exceptions:** Most drugs follow Phase-1 followed by Phase-2. However, **Isoniazid** undergoes Phase-2 (Acetylation) before Phase-1 (Hydrolysis). * **Morphine-6-Glucuronide:** A rare example where a Phase-2 metabolite is more pharmacologically active than the parent drug.

Q: What is the most common Phase I biotransformation reaction?

Oxidation. **Explanation:** Drug metabolism (biotransformation) occurs in two phases. **Phase I reactions** (Non-synthetic) involve the introduction or unmasking of a functional group (–OH, –NH2, –SH) to make the molecule more polar. Among these, **Oxidation** is the most common and important Phase I reaction. It is primarily mediated by the **Cytochrome P450 (CYP450)** enzyme system located in the smooth endoplasmic reticulum of hepatocytes. **Analysis of Options:** * **Oxidation (Correct):** It involves the addition of oxygen or removal of hydrogen. It is the predominant pathway for most drugs (e.g., Phenytoin, Barbiturates). * **Reduction:** This involves the addition of hydrogen or removal of oxygen. It is less common than oxidation but important for drugs like Chloramphenicol and Halothane. * **Hydrolysis:** This is the cleavage of a bond by adding water. It occurs in the plasma or tissues for esters (e.g., Procaine, Aspirin) and amides (e.g., Lidocaine). * **Cyclisation:** This is a minor Phase I reaction involving the formation of a ring structure from a straight chain (e.g., Proguanil). **High-Yield Clinical Pearls for NEET-PG:** * **Phase I vs. Phase II:** Phase I reactions generally result in metabolites that are active, inactive, or even more toxic. Phase II (Conjugation) reactions almost always result in **inactive, highly polar, and easily excretable** metabolites. * **Glucuronidation:** While Oxidation is the most common Phase I reaction, **Glucuronide conjugation** is the most common Phase II reaction. * **Microsomal Enzymes:** CYP3A4 is the most abundant CYP isoform in the liver and is responsible for metabolizing nearly 50% of all clinically used drugs. * **Exception:** Most drugs undergo Phase I followed by Phase II, but some (like Isoniazid) undergo Phase II (Acetylation) before Phase I (Hydrolysis).

Q: What is the value of intrinsic activity for a partial agonist?

Between 0 and +1. ### Explanation **Intrinsic Activity (α)** refers to the ability of a drug to activate a receptor and produce a maximal biological response once it has bound to it. It is measured on a scale from -1 to +1. **Why the Correct Answer is Right:** A **Partial Agonist** binds to a receptor but, even at 100% receptor occupancy, it cannot elicit the maximal response (Emax) that a full agonist would. Therefore, its intrinsic activity is greater than zero (it does produce a response) but less than one (the response is sub-maximal). * **Mathematical Value:** 0 < α < 1. * **Clinical Significance:** In the presence of a full agonist, a partial agonist acts as a **competitive antagonist** because it occupies receptors but produces a weaker effect, effectively "damping" the overall response (e.g., Buprenorphine in opioid use). **Why Other Options are Wrong:** * **Option A (1):** This is the intrinsic activity of a **Full Agonist**, which produces the maximum possible biological response. * **Option B (0):** This is the intrinsic activity of a **Competitive Antagonist**. It has affinity (binds to the receptor) but zero intrinsic activity (produces no response). * **Option D (-1):** This is the intrinsic activity of an **Inverse Agonist**. It binds to the receptor and produces an effect opposite to that of an agonist (decreases constitutive activity). **High-Yield NEET-PG Pearls:** 1. **Affinity vs. Intrinsic Activity:** All agonists and antagonists have affinity, but only agonists (full/partial/inverse) have intrinsic activity. 2. **Pindolol:** A classic example of a partial agonist (Beta-blocker with Intrinsic Sympathomimetic Activity). 3. **Varenicline:** A partial agonist at nicotinic receptors used for smoking cessation. 4. **Aripiprazole:** An atypical antipsychotic that acts as a partial agonist at $D_2$ receptors.

Q: What is the duration of action of omeprazole?

24-48 hours. **Explanation:** The duration of action of Omeprazole is **24-48 hours**, despite its remarkably short plasma half-life (approx. 1-1.5 hours) [1]. This discrepancy is a classic example of a **"Hit and Run" drug**. **Why D is correct:** Omeprazole is a Proton Pump Inhibitor (PPI) that acts as an irreversible inhibitor of the **H+/K+ ATPase pump** in gastric parietal cells [1], [2]. As a prodrug, it is activated in the acidic canaliculi and forms a covalent disulfide bond with the pump [1], [2]. Because the inhibition is **irreversible**, acid secretion can only resume once the parietal cell synthesizes *new* pump proteins [1], [2]. This biological turnover takes significantly longer than the time the drug remains in the blood, leading to a prolonged clinical effect (24-48 hours). **Why other options are incorrect:** * **A (1-2 hours):** This reflects the **plasma half-life** ($t_{1/2}$) of the drug, not its pharmacodynamic duration of action [1]. * **B & C (4-16 hours):** These durations are too short for an irreversible inhibitor. While acid suppression begins quickly, the peak effect and the time required for pump regeneration extend well beyond 16 hours. **High-Yield Clinical Pearls for NEET-PG:** * **Activation:** PPIs are acid-labile prodrugs; they require an acidic environment for activation but must be administered in enteric-coated forms to prevent premature degradation in the stomach lumen [1], [2]. * **Timing:** They should be taken **30-60 minutes before a meal** (usually breakfast) to ensure peak drug levels coincide with the maximal activation of proton pumps during feeding [1]. * **Drug Interaction:** Omeprazole inhibits **CYP2C19**, which can reduce the activation of the antiplatelet drug **Clopidogrel**.

Question 1

Which of the following can be utilized to determine if a drug is a competitive or non-competitive inhibitor?

Accepted Answer

Dose-Response Curve (DRC)

Answer

Potency

Answer

Efficacy

Answer

All of the above

Question 2

Which of the following is a prodrug?

Accepted Answer

Enalapril

Answer

Clonidine

Answer

Salmeterol

Answer

Acetazolamide

Question 3

Autoinduction of biotransformation and action as a hormone is seen in:

Accepted Answer

Thyroxine

Answer

Carbamazepine

Answer

Cimetidine

Answer

Corticosteroid

Question 4

What is the volume of distribution for chloroquine?

Accepted Answer

Above 1300 L

Answer

5–8 L

Answer

9–15 L

Answer

100–650 L

Question 5

Which of the following is true regarding the receptor action of a drug?

Accepted Answer

An antagonist has affinity but no intrinsic activity for a receptor.

Answer

An antagonist has both intrinsic activity and affinity for a receptor.

Answer

A partial antagonist has no intrinsic activity or affinity for a receptor.

Answer

Intrinsic activity and affinity are not important for drug action.

Question 6

Therapeutic drug monitoring is advised in all drugs except which one of the following?

Accepted Answer

Metformin

Answer

Phenytoin

Answer

Tacrolimus

Answer

Cyclosporine

Question 7

Phase-2 reactions in drug metabolism are primarily characterized by which of the following processes?

Accepted Answer

Conjugation

Answer

Oxidation

Answer

Hydroxylation

Answer

Cyclization

Question 8

What is the most common Phase I biotransformation reaction?

Accepted Answer

Oxidation

Answer

Hydrolysis

Answer

Cyclisation

Answer

Reduction

Question 9

What is the value of intrinsic activity for a partial agonist?

Accepted Answer

Between 0 and +1

Answer

1

Answer

0

Answer

-1

Question 10

What is the duration of action of omeprazole?

Accepted Answer

24-48 hours

Answer

1-2 hours

Answer

4-8 hours

Answer

8-16 hours

Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics — MCQs

On this page

Practice by Chapter

Want unlimited practice?